Publications by authors named "Fritz C Offner"

Claim this Profile
G
Glofitamab, a Novel, Bivalent CD20-Targeting T-Cell-Engaging Bispecific Antibody, Induces Durable Complete Remissions in Relapsed or Refractory B-Cell Lymphoma: A Phase I Trial.
Martin Hutchings, Franck Morschhauser, Gloria Iacoboni, Carmelo Carlo-Stella, Fritz C Offner

J Clin Oncol· June 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Randomized Phase II Trial Comparing Obinutuzumab (GA101) With Rituximab in Patients With Relapsed CD20+ Indolent B-Cell Non-Hodgkin Lymphoma: Final Analysis of the GAUSS Study.
Laurie H Sehn, Andre Goy, Fritz C Offner, Giovanni Martinelli, M Dolores Caballero

J Clin Oncol· October 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Symptoms and toxicity of rituximab maintenance relative to observation following immunochemotherapy in patients with follicular lymphoma.
Xiaolei Zhou, Jianmin Wang, Jessica Zhang, Catherine Copley-Merriman, Yasuhiro Torigoe, Fritz C Offner

Hematology· April 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of organ dysfunction on mortality in ICU patients with hematologic malignancies.
Dominique M Vandijck, Pieter O Depuydt, Fritz C Offner, Joke Nollet, Renaat A Peleman

Intensive Care Med· October 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The impact of the initial ventilatory strategy on survival in hematological patients with acute hypoxemic respiratory failure.
Pieter O Depuydt, Dominique D Benoit, Carl D Roosens, Fritz C Offner, Lucien A Noens

J Crit Care· March 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase III study of R-CVP compared with cyclophosphamide, vincristine, and prednisone alone in patients with previously untreated advanced follicular lymphoma.
Robert Marcus, Kevin Imrie, Philippe Solal-Celigny, John V Catalano, Anna Dmoszynska, Fritz C Offner

J Clin Oncol· October 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of recent intravenous chemotherapy on outcome in severe sepsis and septic shock patients with hematological malignancies.
Dominique M Vandijck, Dominique D Benoit, Pieter O Depuydt, Fritz C Offner, Stijn I Blot

Intensive Care Med· May 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Outcome in severely ill patients with hematological malignancies who received intravenous chemotherapy in the intensive care unit.
Dominique D Benoit, Pieter O Depuydt, Koenraad H Vandewoude, Fritz C Offner, Tom Boterberg

Intensive Care Med· January 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Documented and clinically suspected bacterial infection precipitating intensive care unit admission in patients with hematological malignancies: impact on outcome.
Dominique D Benoit, Pieter O Depuydt, Renaat A Peleman, Fritz C Offner, Koenraad H Vandewoude

Intensive Care Med· July 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Outcome in critically ill medical patients treated with renal replacement therapy for acute renal failure: comparison between patients with and those without haematological malignancies.
Dominique D Benoit, Eric A Hoste, Pieter O Depuydt, Fritz C Offner, Norbert H Lameire

Nephrol Dial Transplant· March 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis